Muutke küpsiste eelistusi

E-raamat: Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework

  • Formaat: 128 pages
  • Ilmumisaeg: 20-Feb-2015
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309304047
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 4,08 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 128 pages
  • Ilmumisaeg: 20-Feb-2015
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309304047
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

SMART Vaccines - Strategic Multi-Attribute Ranking Tool for Vaccines - is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I. The 2013 Phase II report refined a beta version of the model developed in the Phase I report.



Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework extends this project by demonstrating the practical applications of SMART Vaccines through use case scenarios in partnership with the Public Health Agency of Canada, New York State Department of Health, and the Serum Institute of India. This report also explores a novel application of SMART Vaccines in determining new vaccine product profiles, and offers practical strategies for data synthesis and estimation to encourage the broader use of the software.

Table of Contents



Front Matter Summary 1 Introduction: SMART Vaccines and Smart Priorities 2 Data Synthesis and Framework 3 Use Case Scenarios and Design Enhancements 4 Reflections and Looking Forward References Appendix A: Use Case Scenarios Report for SMART Vaccines Appendix B: Committee's Response to the Use Case Scenarios Report Appendix C: SMART Vaccines Software Updates Appendix D: Stakeholder Speakers Appendix E: Biographical Information
Disclaimer xiii
Summary 1(10)
1 Introduction: Smart Vaccines And Smart Priorities
11(8)
Project Context and Scope
12(2)
Project Process and Stakeholders' Feedback
14(1)
Use Case Scenarios and Data Synthesis
15(4)
2 Data Synthesis And Framework
19(12)
Data Requirements
19(2)
Attributes and Boundary Setting
21(6)
Current Algorithms for Setting Boundaries
27(2)
Considerations for Modifying Boundaries
29(1)
Data Framework
29(2)
3 Use Case Scenarios And Design Enhancements
31(32)
User Group Scenarios
31(2)
Data Sourcing Guidance to the User Groups
33(1)
Updated Features in SMART Vaccines 1.1
33(12)
Two Aspects of SMART Scores
45(2)
Key Insights from the User Groups
47(1)
Fourth Use Case Scenario: Product Profile Design
48(15)
4 Reflections And Looking Forward
63(18)
Transition Paths
64(1)
Ensuring the Growth and Value of SMART Vaccines
65(2)
An Active User Network
67(2)
Outreach and Awareness Enhancement
69(1)
Data Development: An Opportunity Awaiting
70(2)
A Web-Based Platform
72(1)
Intellectual Property Considerations
73(1)
Future Improvements and Research
74(3)
Expanded Uses of SMART Vaccines
77(2)
Overcoming Barriers to Change
79(2)
REFERENCES
81(4)
APPENDIXES
A Use Case Scenarios Report for SMART Vaccines
85(8)
B Committee's Response to the Use Case Scenarios Report
93(6)
C SMART Vaccines Software Updates
99(4)
D Stakeholder Speakers
103(2)
E Biographical Information
105